Vencanna Ventures Inc. · CSE:VENI
Vencanna Ventures — Investor Presentation (March 2020)
17 slides from Vencanna Ventures's investor presentation, March 2020
Slide 1: Providing Capital to the World's Fastest Growing Industry
PROVIDING CAPITAL TO THE WORLD’S FASTEST GROWING INDUSTRY March 2020
Slide 2: Disclaimer
Disclaimer This corporate presentation contains “forward-looking statements”, within the meaning of We believe the expectations represented by our forward-looking statements are applicable Canadian securities laws . Forward-looking statements can be identified by the use of reasonable, yet there can
Slide 3: Mission
Mission: Vencanna aims to provide capital, liquidity and expertise to early stage jurisdictionally compliant cannabis initiatives thereby providing our investors with a high growth cannabis investment strategy. 3
Slide 4: Key Drivers – The Path Forward
Key Drivers – The Path Forward State Compliant First Mover Advantage Value Add Opportunities Utilize our Strong Balance Sheet Quality and Operational Excellence 4
Slide 5: Who We Are – Executive Team
Who We Are – Executive Team David McGorman 25 years of experience in the financial services and investment banking industry having participated in over CEO & Director $12 billion in transactions; including private and public equity issues, debt placements, M&A advisory services and restructuring ass
Slide 6: Who We Are – Independent Directors
Who We Are – Independent Directors Matt Christopherson Former founder, President and CEO of HighArchy Cannabis Group (and in-house retail brand, “WestCoast Director Cannabis Store”), former founder and EVP of Keirton Inc. (provider of the world’s fastest and most dependable cannabis harvesting machi
Slide 7: Team Strengths & Expertise
Team Strengths & Expertise Strong track record as both investor and founder Industry of cannabis companies Operating experience throughout the value chain; Operations cultivation, processing, product placement, and distribution Over 100 years of combined corporate finance, Capital Markets capital ma
Slide 8: Timeline to Current
Timeline to Current Top Strike Resources Corp. (dba Vencanna announces strategic loan; Vencanna announces the retirement of Vencanna Ventures “Vencanna”) $4 million to Vertical Companies the $4 million loan to Vertical, along with completes Management Recap (“Vertical”) $0.71 million in aggregate in
Slide 9: State Stats – New Jersey and Ohio
State Stats – New Jersey and Ohio New Jersey Ohio Population 8,882,190 11,689,100 Patients 70,201 84,023 Medical 19 – Including anxiety, chronic pain, 21 – Including chronic pain & PTSD Conditions opioid use disorder & PTSD Go-Rec Ballot Initiative for November 2020 Ballot Initiative for November 20
Slide 10: Galenas Ohio
Galenas Ohio • One of 32 licensed cultivators in the state of Ohio and the only organic licensed and operational cultivator in the state. • Vertical three-tier-grow, patient-focused, craft cannabis cultivator located in Akron, Ohio. • 10,0000 sq. ft. facility won Architect Newspaper’s 2019 Best Gree
Slide 11: Vencanna Snapshot
Vencanna Snapshot Balance Sheet C$4.1 million in cash and no debt Galenas Ohio - US$3.3 million convertible debenture (US$3.8 mm outstanding) - Convertible at holders' option into 35% equity Galenas New Jersey Assets - 60% / 54% interest in NJ cultivation and dispensary application respectively - Li
Slide 12: Market Overview
Market Overview 12
Slide 13: U.S. Cannabis Market – World's Largest
U.S. Cannabis Market – World’s Largest 36 11 $75B U.S. TOTAL ECONOMIC MEDICALLY ADULT USE IMPACT BY 2030 LEGAL STATES STATES + D.C. OF THE U.S $18B 74% POPULATION NOW U.S. Est 2020 revenues LIVES IN A STATE WHERE CANNABIS HAS BEEN LEGALIZED 77% Est % of worldwide revenues ➢ Dec. 1, 2019 – Michigan b
Slide 14: U.S. Market Developments
U.S. Market Developments ➢ Progressive attitude towards cannabis continues - 67% support recreational legalization including for the first time republican support above 50% ➢ June 2019 – Congress expands the original Rohrabacher-Farr amendment (denying funds to the DOJ to prosecute medical cannabis
Slide 15: Global Cannabis Index – A Year in Review
Global Cannabis Index – A Year in Review Global Cannabis Index Decline MSO Showing Q3oQ2 Growth vs Cdn LP’s • 10 out of the past 11 months (Feb 2020 • Cresco, Curaleaf, GTI, Harvest, Trulieve > 20% Global index down 21.5%) Bankruptcies on the Rise Capital Available – Focus is Larger and US • DionyMe
Slide 16: Vencanna Ventures
Vencanna Ventures Exclusively positioned in the high growth and highly fragmented US Cannabis market PROHIBITION IS ENDING 16
Slide 17: [email protected]
QP vencanna o VENTURES — _ [email protected] QP vencanna
Vencanna Ventures — Investor Presentation (March 2020) on 6ix